# Correction: Met Is the Most Frequently Amplified Gene in Endometriosis-Associated Ovarian Clear Cell Adenocarcinoma and Correlates with Worsened Prognosis

PMC · DOI: 10.1371/journal.pone.0342829 · PLOS One · 2026-02-17

## Full-text entities

- **Genes:** SLTM (SAFB like transcription modulator) [NCBI Gene 79811] {aka Met}, AKT2 (AKT serine/threonine kinase 2) [NCBI Gene 208] {aka HIHGHH, PKBB, PKBBETA, PRKBB, RAC-BETA}, MET (MET proto-oncogene, receptor tyrosine kinase) [NCBI Gene 4233] {aka AUTS9, DA11, DFNB97, HGFR, RCCP2, c-Met}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, CCL14 (C-C motif chemokine ligand 14) [NCBI Gene 6358] {aka CC-1, CC-3, CKB1, HCC-1, HCC-1(1-74), HCC-1/HCC-3}, ADA2 (adenosine deaminase 2) [NCBI Gene 51816] {aka ADGF, CECR1, IDGFL, PAN, SNEDS, VAIHS}
- **Diseases:** Ovarian Clear Cell Adenocarcinoma (MESH:D010051), endometrioid adenocarcinoma (MESH:D018269), Endometriosis (MESH:D004715)
- **Chemicals:** DAPI (MESH:C007293), serine (MESH:D012694)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12912569/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12912569/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12912569/full.md

---
Source: https://tomesphere.com/paper/PMC12912569